Maprotiline: Clinical Trials

1 trial of Maprotiline, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 withdrawn. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Withdrawn 1

Follow Maprotiline: new trials by email Literature Review of Maprotiline trials Research Report on Maprotiline

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma
Temozolomide, Tamoxifen, Maprotiline - Glioblastoma, Brain Tumor
Phase 1WithdrawnUniversity of Rochester2022-06-012022-08-22

Conditions studied

Brain Neoplasms (1)  ·  Glioblastoma (1)

Sponsors

University of Rochester (1)

Top investigators

Nimish Mohile, MD (1)